Boston Scientificvs.Intuitive Surgical
BSX vs ISRG · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Intuitive Surgical is about 1.9× larger than Boston Scientific by market cap; Boston Scientific trades at the lower P/E (20.4 vs 45.2); year to date, Intuitive Surgical leads (−34.0% vs −48.6%).
Side by side
| BSX | ISRG | |
|---|---|---|
| Market cap | $75B | $142B |
| Price | $49.86 | $371.84 |
| Today | +1.7% | −0.5% |
| Return YTD | −48.6% | −34.0% |
| Return 1Y | −53.8% | −21.5% |
| P/E | 20.4 | 45.2 |
| P/S | 3.6 | 12.8 |
| P/B | 3.0 | 7.8 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Boston ScientificBSX
Cardiology drives the growth, particularly electrophysiology, where Farapulse sits, and structural heart treatment. Endoscopy and urology cover the rest of the range.
Full BSX profile →Intuitive SurgicalISRG
The da Vinci systems brought robot assistance to minimally invasive surgery and are used worldwide. Ion applies the same approach to lung biopsy, and instruments and servicing follow the installed base.
Full ISRG profile →More BSX & ISRG comparisons
Other head-to-heads in the Medtech & devices segment.